A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease. - Test2 - elhamkhani - TriplyDB

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.

http://www.wikidata.org/entity/Q34520640

about

Psychological interventions for treatment of inflammatory bowel disease Aminosalicylates for induction of remission or response in Crohn's disease Enteral nutritional therapy for induction of remission in Crohn's disease Psychological interventions for treatment of inflammatory bowel disease Exaggerated inflammatory response of primary human myeloid dendritic cells to lipopolysaccharide in patients with inflammatory bowel disease Aminosalicylates for induction of remission or response in Crohn's disease Fecal immunochemical test as a biomarker for inflammatory bowel diseases: can it rival fecal calprotectin?Diagnosis and management of functional symptoms in inflammatory bowel disease in remission Diet therapy for inflammatory bowel diseases: The established and the new Ustekinumab for the treatment of Crohn's disease: can it find its niche?National Institutes of Health Consensus Development Project on Criteria for Clinical Trials in Chronic Graft-versus-Host Disease: VI. The 2014 Clinical Trial Design Working Group Report Adalimumab treatment in Crohn's disease: an overview of long-term efficacy and safety in light of the EXTEND trial Use of the tumor necrosis factor-blockers for Crohn's disease Pharmacogenetics in inflammatory bowel disease How accurate are clinical activity indices for scoring of disease activity in inflammatory bowel disease (IBD)?Quantifying your body: a how-to guide from a systems biology perspective Is there an association between inflammatory bowel diseases and carotid intima-media thickness? Preliminary data.Measurement of Inflammatory Bowel Disease Symptoms: Reliability of an Abbreviated Approach to Data Collection Effect of oral lactulose on clinical and immunohistochemical parameters in patients with inflammatory bowel disease: a pilot study.The diagnosis and treatment of Crohn's disease and ulcerative colitis The effects of thiopurine therapy on health-related quality of life in Inflammatory Bowel Disease patients Dysbiosis of gut fungal microbiota is associated with mucosal inflammation in Crohn's disease Inflammatory bowel disease in Korea: epidemiological, genomic, clinical, and therapeutic characteristics.Conventional therapy for Crohn's disease Aberrant plasmacytoid dendritic cell distribution and function in patients with Crohn's disease and ulcerative colitis.Randomized controlled trial: moxibustion and acupuncture for the treatment of Crohn's disease.Assessing health status in inflammatory bowel disease using a novel single-item numeric rating scale.Low-dose azathioprine effectively improves mucosal healing in Chinese patients with small bowel Crohn's disease.Abnormally expressed ER stress response chaperone Gp96 in CD favours adherent-invasive Escherichia coli invasion.Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease.A randomized controlled trial of the efficacy and safety of CCX282-B, an orally-administered blocker of chemokine receptor CCR9, for patients with Crohn's disease Peripheral monocyte functions and activation in patients with quiescent Crohn's disease.Review article: biological agents in the treatment of Crohn's disease.Crohn's disease: the first visit Role of conventional therapies in the era of biological treatment in Crohn's disease.What do I do in my practice that isn't evidence based?Utility of the diffusion-weighted imaging for activity evaluation in Crohn's disease patients underwent magnetic resonance enterography.Assessing patients' satisfaction with anti-TNFα treatment in Crohn's disease: qualitative steps of the development of a new questionnaire.Evaluation of new therapies for inflammatory bowel disease.Is moderate red wine consumption safe in inactive inflammatory bowel disease?

P2860

Q24234176-D4733482-DEAB-4135-BD53-E63F7E29D669 Q24235730-B6A2A639-7769-4955-B1D4-3F0EB37C5102 Q24243037-7B430983-8F26-4F5D-B85A-57BC8D6A7806 Q24243610-18402EB3-ACB5-44CF-AF7A-A13D59C18D0F Q24653651-C46649A4-4948-4A75-BF07-522E287FE147 Q26471183-6355DDDF-8232-4D69-8572-21BBB2EB8C9D Q26765352-ECBADAB2-9666-44BF-85B3-A82E41D0610B Q26768264-FF6C0365-B100-48DC-93CE-D66604B67631 Q26768564-66A81EAC-B067-4DEE-98F6-86E2DE3832CA Q26771890-309750E9-75BD-40A9-8E0F-CD8800506111 Q26827651-BE6B211B-16C5-48F0-9D08-46B4A1ADD84B Q26829488-60F780D2-C69F-40CF-852F-FB8A26D1FDFC Q27030762-C3F144EC-DB9F-4E56-8117-8CCD651AA16E Q28246002-802EFE13-BF83-41A0-9662-B8F3DFB4F921 Q28251305-B5BC5424-4CC3-456E-A28E-4B1D57C5E858 Q28272991-68CF8373-8B92-436B-91CB-3F1AC7ED8767 Q30643321-EB4A616A-EF7E-495A-90AB-925BA29B0750 Q30981629-EFE7EB74-4B35-43B9-8ABD-AE456B35B7A9 Q33296911-A4B8FCE7-BDF5-4A21-868D-C2A3FFEA5B4C Q33476811-CFB29B93-989A-4F29-932C-A28D342C8968 Q33536129-325A7EE0-450C-4403-AB30-92D469D34E16 Q33762994-169503B1-4D46-4BB1-AD3D-6680B0F224C4 Q33855714-E940351A-5210-4066-BE2D-53E91B7EDE3E Q33866982-98FAB297-487A-4E63-ACA9-6644EF579977 Q33962421-DB895E1C-8369-4736-94A6-09965BE35307 Q34067969-47125D5F-F172-4171-887F-0FCAEE25DA0E Q34165218-318DAB48-C446-4988-B57B-90BD82DB691A Q34174683-A495017A-89E5-4E0F-86AC-C42EF93B6697 Q34289782-F691E8D6-EC76-463C-B8E7-A540D14E9EF9 Q34538353-99B107C0-582B-4636-AF26-2725390360EE Q34635636-CB3E523D-F43A-4756-9306-DC84468D6C8B Q34712193-1866967E-784D-4DBC-B9FB-1BBE24680DB3 Q34799343-77FF9E4A-73D6-4BD1-A8D9-B7F717596729 Q34811529-9BE781E7-72B8-41A4-848E-8807FEC120A8 Q34831072-757FEFE4-2D31-415E-AAE9-F3B5BAD89FDC Q35010169-CC0264AE-3523-4EA1-AC81-C3A4F687B51E Q35068215-0AEF3936-00A9-4C1A-A7FA-54E5409CDC44 Q35186984-BD888CB5-BE46-4807-915A-99A369412CDA Q35216827-3C3B5AB7-E357-45A4-916E-356818B615DE Q35233663-9CA9CD3F-3D3B-47FB-920B-F80D683B50D9

P2860

A review of activity indices and efficacy endpoints for clinical trials of medical therapy in adults with Crohn's disease.

http://www.wikidata.org/entity/Q34520640

description

2002 nî lūn-bûn

@nan

2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած

@hyw

2002 թվականի փետրվարին հրատարակված գիտական հոդված

@hy

2002年の論文

@ja

2002年論文

@yue

2002年論文

@zh-hant

2002年論文

@zh-hk

2002年論文

@zh-mo

2002年論文

@zh-tw

2002年论文

@wuu

name

A review of activity indices a ...... n adults with Crohn's disease.

@ast

A review of activity indices a ...... n adults with Crohn's disease.

@en

A review of activity indices a ...... n adults with Crohn's disease.

@nl

type

label

A review of activity indices a ...... n adults with Crohn's disease.

@ast

A review of activity indices a ...... n adults with Crohn's disease.

@en

A review of activity indices a ...... n adults with Crohn's disease.

@nl

prefLabel

A review of activity indices a ...... n adults with Crohn's disease.

@ast

A review of activity indices a ...... n adults with Crohn's disease.

@en

A review of activity indices a ...... n adults with Crohn's disease.

@nl

P1433

Q34520640-DDA31AFC-A102-4050-9D99-3D3B3545F762

P1476

Q34520640-2E99768F-85D9-4AE2-8055-DEAE5682D58B

P2093

Q34520640-09E550C9-6188-48C1-B752-936870EFC1DA

Q34520640-412A7577-AE90-4FE4-B85D-9967012C2C6E

Q34520640-82D138BC-C112-4BF4-81EE-13A997D81317

Q34520640-A9048D61-CB23-46D8-9F1F-DFC260B331E9

Q34520640-AEF698EE-E395-442C-8157-0756949C0E3E

Q34520640-B41B3092-5CE7-48A7-AC93-F66707C05532

Q34520640-B967A28A-A1F0-4004-8C6E-5A0036FBF856

Q34520640-D7A672AA-6FB0-4622-9B7E-A444096059E0

P304

Q34520640-35908602-3538-41BA-AE20-C94CE0D5A474

P31

Q34520640-4FFC4CA4-0241-4FB6-9F8B-DE68C6AE9526

P356

Q34520640-CE6629CE-C106-43E5-B455-08F38F8FF896

P407

Q34520640-67FF5A45-E5D4-4A44-B2BB-8696025234E9

P433

Q34520640-FAFDADED-EEFC-490D-AD6B-8433513A986F

P478

Q34520640-E43D928D-22C9-4818-8564-BB4E0E10FA68

P50

Q34520640-14B142CF-B79D-4BE7-ABEC-AE97F2CDE800

Q34520640-3121061E-3553-45B0-AFBF-2EC6833B068C

Q34520640-C55620D4-8C58-4B59-AA08-1C800BEBEC87

P577

Q34520640-00F8E16B-26EC-4BF6-9E7F-66350379608B

P5875

Q34520640-63BD35ED-179A-4414-B71D-1B594A47D27F

P698

Q34520640-28C9DA13-B668-4969-8CA2-2570F90EE88D

P921

Q34520640-560D3273-1782-43F5-B040-881D9DEAF6A3

P356

GAST.2002.31072

P1433

Gastroenterology

P1476

A review of activity indices a ...... n adults with Crohn's disease.

@en

P2093

Daniel H Present

http://www.w3.org/2001/XMLSchema#string

Eduard F Stange

http://www.w3.org/2001/XMLSchema#string

Herbert Lochs

http://www.w3.org/2001/XMLSchema#string

Jurgen Schölmerich

http://www.w3.org/2001/XMLSchema#string

Lloyd R Sutherland

http://www.w3.org/2001/XMLSchema#string

Robert Löfberg

http://www.w3.org/2001/XMLSchema#string

Robert Modigliani

http://www.w3.org/2001/XMLSchema#string

Stephen B Hanauer

http://www.w3.org/2001/XMLSchema#string

P304

512-530

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/GAST.2002.31072

http://www.w3.org/2001/XMLSchema#string

P407

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

122

http://www.w3.org/2001/XMLSchema#string

P50

William Jeffery Sandborn

Brian G. Feagan

P577

2002-02-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

11529173

http://www.w3.org/2001/XMLSchema#string

P698

11832465

http://www.w3.org/2001/XMLSchema#string

P921

Crohn's disease